THE THORNTON PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: P81079 | THORNTON-CLEVELEYS, FY5 2TZ
Showing results 601-650 of 662
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Vitamins caps | 13 | 748 | £14 | -76.3% ▼ |
| Other toiletry preparations | 13 | 5,650 | £66 | -69.6% ▼ |
| 13 | 279 | £74 | -67.0% ▼ | |
| 13 | 231 | £64 | -56.5% ▼ | |
| 13 | 250 | £549 | +89.3% ▲ | |
| 13 | 165 | £187 | -60.4% ▼ | |
| Propafenone hydrochloride | 12 | 1,080 | £99 | +10.8% ▲ |
| Co-tenidone (Atenolol/chlortalidone) | 12 | 336 | £15 | -42.5% ▼ |
| Prazosin hydrochloride | 12 | 1,344 | £59 | -28.7% ▼ |
| Losartan potassium with diuretic | 12 | 336 | £37 | -53.2% ▼ |
| Ciprofibrate | 12 | 336 | £855 | -10.1% ▼ |
| Chloral hydrate | 12 | 7,200 | £11.7K | +18.5% ▲ |
| Sulpiride | 12 | 680 | £57 | -55.2% ▼ |
| Reboxetine | 12 | 672 | £203 | -22.1% ▼ |
| Deflazacort | 12 | 1,008 | £254 | +36.0% ▲ |
| Ciclosporin | 12 | 342 | £391 | -28.1% ▼ |
| Powder amino acid formula (0913131) | 12 | 52.8K | £5.1K | +12.5% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 12 | 336 | £12 | -20.1% ▼ |
| Levofloxacin | 12 | 960 | £546 | +182.8% ▲ |
| Mupirocin | 12 | 270 | £95 | +29.3% ▲ |
| Amorolfine hydrochloride | 12 | 100 | £124 | -48.0% ▼ |
| 12 | 385 | £344 | +9.6% ▲ | |
| 12 | 720 | £1.1K | +44.7% ▲ | |
| 12 | 170 | £255 | -63.4% ▼ | |
| 12 | 1,080 | £2.8K | +36.6% ▲ | |
| 12 | 240 | £781 | +2.2% ▲ | |
| Levodopa/carbidopa/entacapone | 11 | 1,232 | £405 | -60.7% ▼ |
| Vardenafil | 11 | 44 | £73 | -21.2% ▼ |
| Exemestane | 11 | 458 | £68 | -66.1% ▼ |
| Sevelamer | 11 | 1,626 | £472 | -49.8% ▼ |
| Other digestive aid preparations | 11 | 330 | £68 | +16.2% ▲ |
| Powder extensively hydrolysed formula with MCT (0913102) | 11 | 42.3K | £1.8K | +97.0% ▲ |
| Powder thickener - starch based (0913161) | 11 | 3,240 | £91 | -23.4% ▼ |
| 11 | 810 | £314 | -25.2% ▼ | |
| 11 | 2,680 | £2.0K | -17.2% ▼ | |
| 11 | 470 | £1.7K | +1.1% vs avg | |
| 11 | 330 | £1.6K | +23.1% ▲ | |
| 11 | 600 | £838 | -13.6% ▼ | |
| 11 | 270 | £1.7K | -13.9% ▼ | |
| Aluminium and magnesium and activated simeticone | 10 | 5,000 | £73 | +167.5% ▲ |
| Mebeverine hydrochloride compound preparations | 10 | 600 | £522 | -11.6% ▼ |
| Aspirin | 10 | 443 | £36 | +1.8% vs avg |
| Liothyronine sodium | 10 | 560 | £1.1K | -53.1% ▼ |
| Indoramin | 10 | 280 | £244 | -34.2% ▼ |
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 10 | 75.0K | £999 | +43.5% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 10 | 8,096 | £397 | -62.4% ▼ |
| Tube feed 1 kcal/ml (0914011) | 10 | 300.0K | £4.0K | +33.3% ▲ |
| Ketotifen fumarate | 10 | 50 | £74 | +7.5% ▲ |
| Atropine sulfate | 10 | 480 | £393 | -21.5% ▼ |
| Calcitriol | 10 | 1,000 | £172 | +88.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.